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Abstract
Background: The relationship between TB/HIV co-infection and common mental disorders (CMD) has been scarcely 
investigated. In this study, we compared the occurrence of CMD in TB/HIV co-infected and non-co-infected HIV 
patients in Ethiopia.
Methods: We conducted a cross sectional study in three hospitals in Ethiopia from February to April, 2009. The study 
population consisted of 155 TB/HIV co-infected and 465 non-co-infected HIV patients. CMD was assessed through face 
to face interviews by trained clinical nurses using the Kessler 10 scale. Several risk factors for CMD were assessed using 
a structured questionnaire.
Results: TB/HIV co-infected patients had significantly (p = 0.001) greater risk of CMD (63.7%) than the non-co-infected 
patients (46.7%). When adjusted for the effect of potential confounding variables, the odds of having CMD for TB/HIV 
co-infected individuals was 1.7 times the odds for non-co-infected patients [OR = 1.7, (95%CI: 1.0, 2.9)]. Individuals who 
had no source of income [OR = 1.7, (95%CI: 1.1, 2.8)], and day labourers [OR = 2.4, 95%CI: 1.2, 5.1)] were more likely to 
have CMD as compared to individuals who had a source of income and government employees respectively. Patients 
who perceived stigma [OR = 2.2, 95%CI: 1.5, 3.2)] and who rate their general health as "poor" [OR = 10.0, 95%CI: 2.8, 
35.1)] had significantly greater risk of CMD than individual who did not perceive stigma or who perceived their general 
health to be "good".
Conclusion: TB/HIV control programs should develop guidelines to screen and treat CMD among TB/HIV co-infected 
patients. Screening programs should focus on individuals with no source of income, jobless people and day labourers.
Background
The global burden of disease report revealed that neurop-
sychiatric conditions accounted for up to a quarter of all
the disability-adjusted life years lost[1]. In low and middle
income countries (LAMIC), neuropsychiatric disorders
such as depression, anxiety and somatoform disorders
account for 9.8% of the global burden of diseases[2].
The risk factors for mental health problems are com-
plex [3]. Poverty, low education, social exclusion, gender
disadvantage, conflict and disasters are the major social
determinants of mental disorders[2]. Presence of medical
illnesses [4] stigma and discrimination [5] also play a role
in the development of depression.
The recent Lancet series on global mental health high-
lighted the lack of research on the interactions between
mental disorders and communicable diseases such as
tuberculosis (TB) and HIV/AIDS in low income settings
[4]. A high rate of depressive disorders has been reported
among patients with HIV in high income countries. In
the United States, a higher rate of depressive disorders
was observed in HIV seropositive women (19%) than in
HIV seronegative women (4.8%)[6]. Bing and colleagues
[7] also reported that the 12-month prevalence of major
depression was 36% in HIV infected adults compared to
7.6% in the general population in the United States. Some
studies in LAMIC (Kenya, Democratic Republic of Congo
and Thailand) also revealed that the rate of depression
was higher in HIV seropositive patients than in HIV neg-
ative individuals [8]. * Correspondence: amare_deribew@yahoo.com
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The neurotropism of the HIV, opportunistic infections
of the central nervous system and side effects of antiret-
roviral therapy (ART), especially the Efavirenz, may cause
mental health problems[4]. There is evidence that indi-
viduals with mental health problems are at higher risk of
contracting HIV due to their higher risk behaviours[9].
Adherence to ART is adversely affected by depres-
sion[10-12]. Moreover, depression may reduce the CD4
lymphocyte count, increase viral load and mortality in
patients with AIDS[13-15]. On the other hand, treatment
of depression has been found to improve health outcomes
in patients with HIV[14,15].
Some studies have investigated the relationship
between common mental disorders (CMD) and TB. A
study conducted in Turkey showed that the prevalence of
depression and anxiety was 19% for recently diagnosed
patients with TB, 22% for defaulted TB patients, and 26%
for patients with multidrug-resistant TB[16]. The preva-
lence of CMD in 53 Nigerian TB patients recruited in a
chest clinic was 30%, compared to 5% in healthy con-
trols[17]. A study done in Pakistan showed that the prev-
alence of depression and anxiety among TB patients was
43% and 47% respectively[18]. TB patients have poor
mental health and quality of life compared to the general
population in United Kingdom[19].
TB/HIV co-infection poses immense diagnostic and
economic challenges for developing countries[20]. HIV is
the strongest risk factor for the development of active
pulmonary and extra pulmonary TB. TB also accelerates
the deterioration of the immune status of patients with
HIV [21-24] and it is one of the leading causes of mortal-
ity in people living with HIV/AIDS (PLHA)[25]. In Ethio-
pia, the rate of TB/HIV co-infection ranges from 45% in
Addis Ababa[26] to 52% in North Ethiopia[27].
Although several studies have been done concerning
the interaction between either HIV/AIDS or TB with
mental health problems, little is known about the effect of
TB/HIV co-infection on common mental disorders.
CMD, characterized by a significant level of depressive,
anxiety and/or somatic symptoms are common among
women in Ethiopia[28,29]. So far the magnitude of CMD
among men and the interaction between CMD and com-
municable diseases has not been investigated in Ethiopia.
The objective of this study was to compare the occur-
rence of CMD in TB/HIV co-infected and non-co-
infected HIV patients in Ethiopia.
Methods
Study Settings and Population
From February to March, 2009, we conducted a cross sec-
tional study in three hospitals in Oromiya regional state
of Ethiopia. Based on the availability of patients, we
selected Adama, Nekemet and Jimma specialized hospi-
t a l s  i n  t h e  e a s t ,  w e s t  a n d  s o u t h w e s t  p a r t  o f  E t h i o p i a
respectively. The methodology of this study is described
elsewhere[30]. In brief, the study population consisted of
155 TB/HIV co-infected and 465 non-co-infected HIV
patients. All TB patients in the first two months of TB
treatment were asked to participate in the study. For each
TB/HIV co-infected patient, 3 non-co-infected HIV
patients were also asked to participate. The latter were
selected using a simple random sampling technique using
the patients' unique identification number in the HIV
clinics. TB was diagnosed using national TB guide-
lines[31]. The non-co-infected patients were also
screened for the presence of any signs and symptoms of
TB. Non-co-infected HIV patients with a prior history of
TB were excluded from the study. Patients who were less
than 15 years old, had TB meningitis or another opportu-
nistic infection, had a chronic illness like diabetes, cardio-
vascular disease or hypertension were excluded from the
study.
Data collection procedures
CMD was assessed through face to face interviews by
trained clinical nurses using the Kessler 10 scale[32]
which consisted of 10 five-point Likert scale (0 = never, 1
= rarely, 2 = some of the time, 3 = most of the time, 4 = all
of the time) questions. For the diagnosis of CMD, the
Kessler 10 scale was validated in Ethiopia against a gold
standard of psychiatrists' diagnosis[28]. In a previous
study, two psychiatrists used the validated Comprehen-
sive Psychopathology Rating Scale (CPRS) to diagnose
CMD[29]. The CPRS has 66 items; 40 symptoms based
on the subjective report of the interviewee, 25 signs rated
on the basis of observation during the interview and a
global rating indicating presence of significant mental
disorder. The presence of clearly defined symptoms or
signs of mental disorder was rated on a 4-point scale (0-
3). The definitions of each scale point were standardized
as follows: 0 = not present; 1 = doubtful whether present,
and not interfering with life; 2 = definitely present and of
moderate severity; 3 = severe or incapacitating. The psy-
chiatrists were asked to conduct a full psychiatric inter-
view and then complete the CPRS ratings using all
available information[28,29]. Caseness of CMD was
determined on the basis of any of the combination of
depressive, anxiety and/or somatic symptoms present at
clinically significant level. At the cut-off point of 6/7, the
Kessler 10 scale had a sensitivity and specificity of 84.2%
and 77.8% respectively to diagnose CMD[28].
Perceived stigma was measured using a questionnaire
adopted from Berger et al[33]. The instrument was highly
reliable in a pre-test (Cronbach's α = 0.93). The stigma
scale consisted of four-point Likert scale (strongly dis-
agree, disagree, agree, strongly agree) questions concern-
ing perceived isolation, shame, guilt and disclosure of the
HIV status. Item scores of the stigma questions wereDeribew et al. BMC Infectious Diseases 2010, 10:201
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summed to construct a single stigma variable. Partici-
pants were classified as having or not having perceived
stigma using the mean of the stigma variable as cut-off
point. Perceived general health of the participants (good,
medium and poor) was assessed by asking the question
'How would you rate your health?'
Medical charts were reviewed to collect clinical infor-
mation and level of adherence to antiretroviral and TB
treatment. Individuals who took more than 95% of the
prescribed doses were labelled as adherent to antiretrovi-
ral therapy.
Data Analysis
Data were analyzed using SPSS version 16.0 software.
Item scores of the Kessler scale were summed and indi-
viduals who scored above the cut-off point of 6/7
[28]were labelled as having CMD. The Pearson's chi-
square test was used to evaluate the association between
exposure variables (TB/HIV co-infection, socio-demo-
graphic and clinical characteristics of the patients) and
CMD. A stepwise logistic regression model was used to
adjust for the effect of confounding variables. Variables
significantly associated (P < 0.05) with CMD or TB/HIV
co-infection in the Pearson's chi-square test were
included in the logistic regression model.
Ethical consideration
Ethical clearance was obtained from the Jimma Univer-
sity ethical review board. Written informed consent was
obtained from the study participants. To ensure confi-
dentiality, we used codes to analyze the data.
Results
All of the 465 non-co-infected HIV patients and 124
(80%) of the co-infected HIV patients participated in the
study; 31 TB/HIV co-infected patients were lost to follow
up before interview. Of the co-infected patients, smear
negative, smear positive and extra pulmonary TB
accounted for 61 (49.2%), 42 (33.9%), 21 (16.9%) respec-
tively. From the total TB/HIV co-infected patients, 4
(3.2%) interrupted their TB treatment once.
The age distribution of TB/HIV co-infected and non-
co-infected patients was similar. Fifty percent of the co-
infected and 60.2% of the non-co-infected HIV patients
were females (P < 0.05). Higher proportion of co-infected
patients (43.5%) had no source of income compared to
the non-co-infected patients (26.7%) [OR = 1.9, (95%CI:
1.0, 3.8)]. After adjusting for confounding variables, co-
infected patients (57.5%) were more likely to have a lower
CD4 lymphocyte count than non-co-infected patients
(27.4%) [OR = 3.6; (95%CI: 2.1, 6.1)]. Before the diagnosis
of TB, significantly larger proportions (78.0%) of the co-
infected patients were in stage III of the WHO classifica-
tion compared to the non-co-infected HIV patients
(56.0%). All of the non-co-infected and 75.6% of the co-
infected patients were taking antiretroviral treatment
during the survey (Table-1).
The internal consistency of the Kessler 10 scale was
high (Cronbach's α = 0.93) and correlation between items
in the Kessler scale ranged from 0.50 to 0.79.
A lower CD4 lymphocyte count, a WHO stage of III
and IV, taking antiretroviral treatment, types of antiretro-
viral therapy, adherence to antiretroviral therapy, age, sex,
literacy and marital status were not significantly associ-
ated with CMD in the bivariate analysis. On the other
hand, occupation, source of income, TB/HIV co-infec-
tion, perceived stigma and perceived general health were
significantly associated with CMD in the bivariate analy-
sis and were therefore further evaluated in the multivari-
able model. Individuals who had no source of income
[OR = 1.7, (95%CI: 1.1, 2.8)], and day laborers [OR = 2.4,
95%CI: 1.2, 5.1)] were more likely to have CMD as com-
pared to individuals who had a source of income and gov-
ernment employees respectively. CMD was present in
63.7% of the TB/HIV co-infected patients and in 46.7% of
the non-co-infected patients. TB/HIV co-infected
patients were 1.7 times more likely to experience CMD
than the non-co-infected patients [OR = 1.7, (95%CI: 1.1,
2.9)]. Patients who perceived stigma [OR = 2.2, 95%CI:
1.5, 3.2)] and who rate their general health as "poor" [OR
= 10.0, 95%CI: 2.8, 35.1)] had significantly greater risk of
CMD than individual who did not perceive stigma or who
perceived their general health to be "good" (Table-2).
Discussion
W e  a s s e s s e d  t h e  o c c u r r e n c e  o f  C M D  i n  T B / H I V  c o -
infected and non-co-infected patients using the Kessler
scale (K10)[28]. Caseness of CMD was assessed using a
cut-off point of 6/7 of the K10 which had a sensitivity and
specificity of specificity of 84.2% and 77.8% against the
psychiatrists' assessment using CPRS. Several studies
showed that the K10 had strong psychometric proper-
ties[32,34-36] and can discriminate between cases and
non-cases reported in the Diagnostic and Statistical Man-
ual of Mental Disorders (DSM-IV)[32,36]. In this study,
79 (64%) of the TB/HIV co-infected patients had CMD
which is higher than the findings of Hanlon et al (33%)
[28] and Tesfaye et al (40%)[28] among women in Ethio-
pia. The prevalence of depression among HIV seroposi-
tive women (19%) in the United States was also lower as
compared to our study[6]. The differences in prevalence
of mental disorders could be attributable to several fac-
tors including the population being studied, the study
periods and the diagnostic tools[29]. TB/HIV co-infected
patients were 1.7 times more likely to have CMD than
non-co-infected HIV patients. However, we did not find a
significant association between CD4 lymphocyte count
and CMD, which is consistent with several previous stud-Deribew et al. BMC Infectious Diseases 2010, 10:201
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Table 1: Socio-demographic and clinical characteristics of the study population in three hospitals of, Ethiopia, April, 2009
Variables TB/HIV coinfected patients HIV patients Crude OR Adjusted OR
Number (%) Number (%) (95%CI) (95%CI)
Age in Years
15-24 12(9.7) 42(9.1) 1 -
25-34 53(42.7) 221(47.5) 0.8(0.4,1.7)
> = 35 59(47.6) 202(43.4) 1.0(0.5,2.1)
Sex
Male 62(50) 185(39.8) 1.5(1.0, 2.2)* 1.9(1.0,3.7)*
Female 62(50) 280(60.2) 1 1
Educational status
Illiterate 30(24.2) 74(15.9) 1 1
literate 94(75.8) 391(84.1) 0.6(0.4, 0.9)* 0.8(0.4,1.6)
Marital status
Single 24(19.3) 75(16.1) 1.3(0.7,2.5) -
Married 42(33.9) 191(41.1) 0.9(0.5,1.6)
Divorced 33(26.6) 93(20.0) 1.5(0.8,2.7)
Widowed 25(20.2) 106(22.8) 1
Occupation (n = 580)
Government worker 17(14.8) 51(11.0) 1 1
Private employee 15(13.1) 83(17.8) 0.5(0.2,1.1) 0.9(0.3,2.7)
Merchant 1(0.9) 69(14.8) 0.4(0.2,1.0) 0.6(0.2,2.3)
Farmer 13(11.3) 32(6.9) 1.2(0.5,2.8) 2.0(0.6,6.5)
Housewives 15(13.0) 79(17.0) 0.6(0.3,1.3) 1.4(0.4,4.7)
Day laborers 22(19.1) 93(20.0) 0.7(0.4,1.5) 1.6(0.6,4.8)
No Job 32(27.8) 58(12.5) 1.6(1.1, 3.4)* 1.7(0.5,5.1)
Have source of income
Yes 70(56.5) 341(73.3) 1 1
No 54(43.5) 124(26.7) 2.2(1.4,3.2)* 1.9(1.0,3.8)*
WHO staging(n = 582)
Stage II 13(10.6) 136(29.6) 1 1
Stage III 96(78.0) 257(56.0) 1.6(1.3,1.9)* 2.3(1.1,4.6)*
Stage IV 14(11.4) 66(14.4) 1.2(0.9,1.5) 1.3(0.5,3.5)
CD4 lymphocyte count(n = 489)
< 200 46(57.5) 112(27.4) 1.9(1.2,2.8)* 3.6(2.1,6.1)*
> = 200 34(42.5) 297(72.6) 1 1
Antiretroviral therapy
Yes 93(75.6) 462(100) 0.02(0.001, 0.04) 0.01(0.001, 0.003)*
No 31(24.4) 3 1
*statistically significant (P < 0.05)Deribew et al. BMC Infectious Diseases 2010, 10:201
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Table 2: Association of socio-demographic and clinical characteristics and CMD in three hospitals of Ethiopia
Variables Common Mental Disorders Crude OR Adjusted OR
Yes (%) No (%) (95%CI) (95%CI)
Sex
Male 132(53.4) 115(46.6) 1
Female 164(48.0) 178(52.0) 0.8(0.5,1.1) -
Literacy status
Literate 236(48.7) 249(51.3) 1 -
Non-literate 60(57.7) 44(42.3) 1.4(0.9,2.2)
Age
15-24 21(38.9) 33(61.1) 1 -
25-35 145(52.9) 129(47.1) 1.7(0.9,3.2)
> = 35 130(49.8) 131(50.2) 1.5(0.8,2.8)
Marital status
Single 48(48.5) 51(51.5) 0.6(0.4,1.0) -
Married 106(45.5) 127(54.5) 0.5(0.4,0.9)
Divorced 65(51.6) 61(48.4) 0.8(0.5,1.2)
Widowed 77(58.8) 54(41.2) 1
Occupation
Government employee 23(33.8) 45(66.2) 1 1
Private employee 49(50.0) 49(50.0) 1.9(1.0, 3.7) * 2.2 (1.1,4.6)*
Merchant 35(44.3) 44(55.7) 1.5(0.8,3.0) 2.1 (1.0,4.4)*
Farmers 24(53.3) 21(46.7) 2.2(1.0, 4.8) * 1.8 (0.8,4.2)
Housewives 40(42.6) 54(57.4) 1.4(0.7,2.7) 1.2 (0.5,2.8)
Day Laborers 66(57.9) 48(42.1) 2.7(1.4, 5.0) * 2.4 (1.2, 5.1) *
Jobless 59(64.8) 32(35.2) 3.6(1.8, 6.9) * 2.5 (1.1,5.6) *
Have source of income
Yes 190(46.2) 221(53.8) 1 1
No 106(59.3) 72(40.7) 1.6(1.2,2.4) * 1.7(1.1,2.8) *
HIV/TB co-infection
No 217(46.7) 248(53.3) 1 1
Yes 79(63.7) 45(36.3) 2.0(1.3,3.0) * 1.7 (1.1,2.9) *
WHO staging(n = 582)
Stage II 73(49) 76(51) 1
Stage III 194(55.0) 159(45.0) 1.1(0.5, 1.2) -
Stage IV 24(30) 56(70) 0.8(0.7, 1.5)
CD4 lymphocyte count(n = 489)
< 200 74(46.8) 84(53.2) 1.2(0.8.1.7) -
> = 200 171(51.7) 160(48.3) 1
Taking antiretroviral therapy
Yes 274(49.4) 281(50.6) 1 -
No 22(64.7) 12(35.3) 1.8(0.9,3.8)
Adherence to antiretroviral therapy(ART)
Yes 285(49.7) 288(50.3) 1 -Deribew et al. BMC Infectious Diseases 2010, 10:201
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ies[37-39]. TB/HIV co-infected patients can be at higher
risk of CMD as a result of stigma and discrimination by
the society[5]. We also found out that perceived stigma
was one of the independent predictors of CMD. People
with perceived stigma may have a low self image and be
socially isolated which may predispose them to CMD[40].
Poverty is known to be a major risk factor for mental
health problems [3]. Many individuals in developing
countries suffer from CMD as a result of stress caused by
poverty[3,41]. In this study, daily labourers and jobless
individuals, both economically disadvantaged groups,
were at a higher risk of CMD. Use of the locally made
alcohol called "Katikala", which is common among daily
labourers in Ethiopia [42], can also predispose to CMD.
In contrast with other studies[3,40,43], we did not
observe a significant association between marital status,
gender and CMD.
In our study, the perception of poor general health was
strongly associated with CMD. However, there could be a
bi-directional relationship between perceived general
health and depression. Poor perceived general health
could have resulted from the presence of CMD.
Although antiretroviral drugs, particularly Efavirenz,
can cause CMD[4], our result did not show an association
between this drug and CMD. Adherence to antiretroviral
t h e r a p y  h a s  b e e n  r e p o r t e d  t o  b e  a f f e c t e d  b y  d e p r e s -
sion[4]. However, in our study we did not observe an
association between adherence and CMD.
Some methodological limitations need to be noted in
interpreting the findings of this study. First, the Kessler 10
scale is not 100% sensitive and specific and we might have
misdiagnosed or missed some cases of CMD. Second, no
detailed validation study was done for the stigma scale.
Third, 20% of the TB/HIV co-infected patients were lost
to follow-up which might introduce information bias.
Important risk factors of CMD such as substance and
alcohol use were not assessed.
Conclusions
TB/HIV co-infected patients were at higher risk of devel-
oping CMD than non-co-infected patients. Occupation,
perceived stigma and perceived general health were other
risk factors for CMD. TB/HIV control programs should
develop guidelines to screen and treat CMD among TB/
HIV co-infected patients. Screening programs should
focus on individuals with no source of income, jobless
people and day labourers. We recommend prospective
cohort study to investigate the cause effect relationship of
risk factors and CMD.
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